Seven hospitals from Austria, Italy, Germany, the Netherlands and France are inviting potentially interested bidders to participate in the open market consultation for their upcoming pre-commercial procurement on Next Generation Sequencing (NGS). The aim is to develop and test two fully integrated, standardized NGS workflows, from sample-pre-analytics to medical decision making, for routine diagnostics of common and rare cancers from adults and children. The open market consultation is planned to take place 22-23 March 2021 in Vienna. Registration deadline: 1 March 2020.

Logo of the project for Instand Next Generation Sequencing for Personalised cancer therapy